Journey to Wealth

RHB Capital - OUTPERFORM - RN - 29 May 2012

kiasutrader
Publish date: Tue, 29 May 2012, 07:20 PM

Period    1Q12

Actual vs.  Expectations
 The 1Q12 PAT of RM436m was within the consensus' forecast (26%) and that of ours (25%). 

Dividends   No dividend was declared.

Key Result Highlights
 The loan book at RM95.5b contracted marginally by 1.8% QoQ due to a major RM2.0b corporate loan repayment. Net interest margin was stable at 2.4% with the net interest incomes of RM709m staying relatively flattish on both QoQ and YoY basis (at 0% and +4% respectively).  

 The stable NIM above (FY11: 2.41%) was due to better liability management, which saw a slowing deposit growth with the L/D down to 81% (from 84% in 4Q11). 

 1Q12 non-interest incomes (excluding Islamic Income contribution) meanwhile came in at RM330.4m, up +16.7% QoQ and +24% YoY as the group achieved higher net gains in FX transactions, securities portfolio and MTM on derivative hedging.  The overall total revenue of RM1,150.4m meanwhile rose 1.2% QoQ and 10.7% YoY.

 The total cost of RM524.4m was 16.9% higher on a YoY basis due to higher staff and admin costs that drove the cost-to-income ratio to 45%.  

 Asset quality improved with the gross impaired loans ratio higher at 3.59% due to the adoption of MFRS139, which resulted in an annualised credit charge ratio of 19bps. However, the loan coverage decreased marginally to 69% (from 74% in 3QFY11).  

 In total, the 1Q12 ROE of 14.7% was within our expectation and management's previous guidance.

Outlook   Its merger with OSKIB is strategically an ideal fit, adding significant diversification of clienteles, regional scale in capital markets and immediate access into other ASEAN markets. (Please refer to our other report today for more details on this.)

Change to Forecasts
 We are maintaining our FY12E PAT of RM1,719.5m and FY13E of RM1,840.6m.

Rating  MAINTAIN  OUTPERFORM
 RHBCAP stands out from its peers as it trades at 1.2x BV compared to its long-term average of 1.8x. In our view, the current price of RHBCAP has ignored its ROE of 11-12% (post new shares issuance for OSKIB merger) and its growth potential as a real challenger to the market leaders.

Valuation    We are adjusting our TP to RM9.00 based on a targeted 1.4x its FY2013 BV to factor the dilution of larger share base.  (Please refer our separate report on RHBCAP for details.)

Risks   Tighter lending rules and a margin squeeze.  

Source: Kenanga
Related Stocks
Market Buzz
Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment